Clicks Group is undeniably a powerhouse on the JSE. It is widely recognised as a well-managed and resilient business. However, a persistent question dogs potential investors, particularly those inclined towards scepticism: is Clicks Group simply too expensive to justify buying? While it’s true that Clicks trades at a premium compared to many other retailers, this doesn’t automatically mean it’s never…
Tag: South Africa
-
Ozempic and Mounjaro are reshaping South Africa’s health market
The landscape of weight management and diabetes treatment in South Africa is undergoing a dramatic transformation. This change is driven by the meteoric rise in popularity of a class of drugs known as GLP-1s, including Ozempic and Mounjaro. These medications, initially developed for Type 2 diabetes, have shown significant efficacy in promoting weight loss. As a result, there is unprecedented…
-
SA’s HIV success story creates new challenges
South Africa’s groundbreaking success in providing antiretroviral treatment (ARVs) to millions has transformed HIV from a death sentence into a manageable chronic condition. Many benefit from this. SA’s HIV success story is evident, with roughly 6 million people now on ARVs in the public sector since the 2004 scale-up. This allows people living with HIV to live longer, healthier lives,…
-
Global Pandemic Treaty: A New Era of Cooperation
In April, World Health Organisation (WHO) member states concluded the negotiations for a new pandemic treaty, often referred to as the Global Pandemic Treaty. These demonstrate a crucial capacity for nations to unite despite escalating geopolitical tensions. Precious Matsoso, co-chair of the negotiating body, delivered this key message at the annual Board of Healthcare Funders (BHF) conference in Cape Town.…
-
Gauteng Health pay chaos sparks doctor fury
The non-arrival of their expected commuted overtime payments left public sector doctors across Gauteng reeling. The Gauteng Health pay chaos blindsided the medical community and caused significant distress. This sudden non-payment, affecting medical staff province-wide, has ignited a firestorm. It exacerbates existing tensions over the Gauteng Department of Health’s controversial plans to cut and alter overtime terms. These changes occur…
-
Antibiotic Resistance Claims Lives of Premature Babies
South Africa is facing a critical public health crisis as antibiotic resistance increasingly undermines life-saving treatments, particularly for vulnerable infants. Experts say that antibiotic-resistant infections are now the leading cause of neonatal mortality in the country. This is especially true among premature babies who are prone to hospital-acquired infections. Antibiotic resistance claims lives needlessly, highlighting the severity of the crisis.…
-
HIV deaths in SA may be four times higher than reported
Concerns over the accuracy of South Africa’s official mortality statistics have been amplified by a recent South African Medical Research Council (SAMRC) study. The study highlights the need to revisit HIV deaths in SA. This is given the potential discrepancies in reported data. The research suggests a dramatic undercounting of HIV-related deaths. These may be potentially four times higher than…
-
PEPFAR Funding Cuts Threaten South Africa’s Health
A concerning new study has highlighted the potentially catastrophic consequences for South Africa’s fight against HIV/AIDS. This could occur if the United States implements PEPFAR funding cuts. Additionally, the South African government does not significantly increase its investment. The research indicates that such a scenario by 2028 could lead to an alarming 65,000 additional AIDS-related deaths. There could also be…
-
Adcock Ingram’s Urizone Wins Trademark Battle
A South African court has ruled in favour of Adcock Ingram and Zambon SPA. It ordered Cipla Medpro to stop using the trademark Furizome for its urinary tract infection (UTI) medication. The court found Furizome to be confusingly similar to the established Urizone trademark, central to Adcock Ingram’s branding strategy. This led to a ruling based on trademark infringement and…
-
NHI Advertising Campaign Proceeds Despite HIV Funding Shortfall
Health Minister Aaron Motsoaledi has confirmed that the Department of Health will proceed with its planned R65.9 million NHI advertising campaign. This decision comes despite facing a severe funding shortfall for critical HIV/AIDS programmes. The Minister cited the need to combat “irrational and negative propaganda” surrounding the NHI as the primary reason for continuing the campaign. HIV Funding Gap Sparks…